<DOC>
	<DOCNO>NCT02671825</DOCNO>
	<brief_summary>The purpose study compare drug blood level multiple formulation inhale PUR0200 reference product without oral charcoal .</brief_summary>
	<brief_title>A PK Study Evaluate PUR0200 Reference Product Healthy Subjects</brief_title>
	<detailed_description>The purpose study compare 5 different formulation PUR0200 reference product . All formulation inhale . In 6 7 study period either PUR0200 reference product inhale fasting condition without oral charcoal . In 7th study period , half subject receive reference oral charcoal half receive reference product without oral charcoal .</detailed_description>
	<criteria>Healthy male female subject Age 18 50 ( inclusive ) year Nonsmokers exsmokers ( stop least 6 month ago ) FEV1 â‰¥80 % predict value Completion 3 training inhalation Pregnant and/or nurse woman . Positive pregnancy test entry visit hospitalization day 0 study period . fertile woman without reliable contraception participation ANY research study within 3 month prior entry visit , simultaneous participation another clinical study blood donation blood loss within last 3 month treatment ANY investigational study drug ( i.e . drug yet approve ) last 3 month entry visit intake administration prescribe systemic topical medication include counter ( OTC ) medication natural food supplement ( e.g . vitamin , garlic , ginger capsule ) within 2 week entry visit current history drug abuse within 5 year entry visit alcohol abuse regular consumption beverage food contain methylxanthines ( i.e . coffee , tea , cola , caffeine contain soda , chocolate ) equivalent 500 mg methylxanthines* per day presence history clinically significant cardiovascular , renal , hepatic , pulmonary , metabolic , endocrine , hematological , gastrointestinal , neurological , psychiatric disease major surgery gastrointestinal tract except appendectomy , pulmonary surgery clinically significant illness ( include upper low respiratory infection and/or candidiasis mouth throat ) within 4 week entry visit acute chronic disease might interfere inhalation , absorption , distribution , metabolism excretion drug special diet due reason , e.g . vegetarian positive serologic finding human immunodeficiency virus ( HIV ) antibody , hepatitis B surface antigen ( HBsAg ) , and/or hepatitis C virus ( HCV ) antibodies excessive physical activity ( 4 time per week 90 minute ) within last 6 month study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Pharmacokinetics</keyword>
</DOC>